Category: Medical
-
STAT+: Pharmalittle: We’re reading about a GSK drug’s comeback, a buyer’s club for a Vertex drug, and more
•
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
-
STAT+: How the first nine drug companies won priority review vouchers from Marty Makary’s FDA
•
WASHINGTON — Commissioner Marty Makary wants the Food and Drug Administration to move more quickly. The launch of a…
-
STAT+: Ro wants to measure ‘food noise’ in obesity care
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
At a gathering of biopharma executives, a moment of wonder — and also of worry
•
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit on Oct. 15-16, that…
-
Opinion: TrumpRx and a most favored nation policy won’t lower prices for patients
•
Recently, President Trump signed a “most-favored nation” executive order on drug prices with a claim that it would…
-
STAT+: Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
•
Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families…
-
STAT+: Trump’s IVF deal spurs hopes — and adjustments — across fertility sector
•
WASHINGTON — The Trump administration’s push to make in vitro fertilization more affordable is changing the outlook and…
-
STAT+: Pharmalittle: We’re reading about a Moderna setback, CVS playing hardball with Gilead, and more
•
Top of the morning to you, and a fine one it is. Blue skies and comfortable breezes are…
-
STAT+: Launch prices for new drugs ‘significantly’ exceed inflation and offer insufficient value, analysis says
•
Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
-
STAT+: Moderna faces CMV woes — but sees hope in cancer pipeline
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: CVS Caremark tells AIDS activists Gilead needs to lower the price of its new HIV drug to get on formularies
•
For the past three months, CVS Caremark has resisted adding a new Gilead Sciences HIV prevention drug to…
-
STAT+: Pharmalittle: We’re reading about a new Trump drug-pricing probe, Novo’s board shake-up, and more
•
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and…
-
STAT+: Novo Foundation ousts board in power struggle
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Companies tout a novel payment model for obesity drugs, other medications in drive to lower costs
•
As pharma companies and President Trump tout initiatives to sell branded medications directly to cash-paying consumers, some entrepreneurs…
-
STAT+: Alector’s dementia drug fails to slow patient decline in late-stage trial
•
An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a…
-
STAT+: Gilead agrees not to raise prices on HIV medicines for state AIDS drug programs
•
After months of tense negotiations, Gilead Sciences has agreed not to boost prices next year for HIV medicines…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement
